JUNS

Conviction 0HealthcareScan · Mon, Oct 19, 2026

Jupiter Neurosciences, Inc. (JUNS) closed at $2.80 (-3.61%) on Oct 19, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 41, RS Rating 1, -97.7% from its 52-week high, -96.0% year to date. Sector: Healthcare · Pharmaceutical Preparations.

JUNS$2.80-3.61%

ResistanceSupportVol 14

Vol MA14 92.9K

Jul 22Aug 7Aug 26Sep 14Oct 1Oct 19

Why JUNS moved

From the StockSetups movers recaps that covered JUNS, newest first. A recap states what was known that day.

Aug 21, 2026Premarket+80.5%
Per Yahoo Finance on August 19, the headline reads: "Real Parkinson's Disease Hope from Jupiter Neurosciences."
Premarket Stock Movers — August 21, 2026: Why USDE, HOWL, JUNS & SUGP Are Surging →

Jupiter Neurosciences, Inc.Pharmaceutical Preparationswww.jupiterneurosciences.com ↗

Price2.80

Change-3.61%

Gap-4.99%

Rel volume0.64×

Avg volume98.02K

Avg $ vol282.9K

SMA 202.81

SMA 503.62

SMA 20022.29

Price vs 50-22.55%

Price vs 200-87.44%

MA stackbearish

50/200 cross—

Supertrenddown · 3.42

RSI (14)41

MACD hist0.13

MACD cross—

Stoch %K / %D44 / 56

ADX (14)18

+DI / −DI29 / 20

RSI divergence—

MACD divergence—

ATR %13.28%

ADR %10.56%

52w high119.00

52w low2.42

From 52w high-97.65%

Above 52w low+15.70%

New 52w highNo

SqueezeOn · 17d

Bollinger width36.25%

%B0.49

Donchian pos38.42%

Donchian high3.68

Donchian low2.25

AVWAP (52w high)9.09

vs AVWAP high-69.20%

AVWAP (52w low)2.82

vs AVWAP low-0.59%

OBV trendUp

Chaikin MF (20)0.02

Today vs 20d0.64×

Avg vol (14d)92.9K

Avg vol (20d)98.02K

Avg $ vol (20d)282.9K

Market cap2.16M

RS Rating1 / 99

RS 3m (vs SPY)-78.88%

RS 6m (vs SPY)-99.47%

RS line new highNo

Trend template0/8

Technical rank12.4

1 week-7.89%

1 month-2.10%

3 months-76.43%

6 months-91.30%

1 year-97.55%

YTD-96.04%

P/E-0.25

P/B-5.89

P/S98.93

P/FCF—

EPS-0.2500

Div yield—

ROE—

ROA-232.48%

Debt/Eq—

Current0.66

EV/EBITDA—

Gross margin80.59%

Net margin—

Rev growth—

EPS growth-254.35%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value2.16M

Revenue24.25K

Net income-2.27M

Gross profit21.06K

Free cash flow—

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out36.28M

Employees5

ListedTue, Dec 3, 2024

Free float7.35M

Float %21.4%

Short interest56.87K

Days to cover0.0d

Short volume10.4%

Squeeze score2 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank12.4 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.64

Support2.30

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in JUNS

All disclosures →

No recent disclosed trades by Congress in JUNS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JUNS

Insider	Side	Shares	Value	Traded	Filed
Cutler Andrew Jon Director · Stock Option (right to buy) · 2026-07-31	Grant	472.22K	—	2026-07-31	2026-08-05
Hayward Marshall A. Chief Scientific Officer · Common Stock · 2026-03-02	Exercise	225K	—	2026-03-02	2026-07-13
Hayward Marshall A. Chief Scientific Officer · Stock Option (right to buy) · 2026-03-02	Exercise	225K	—	2026-03-02	2026-07-13
Hayward Marshall A. Chief Scientific Officer · Restricted Stock Units · 2025-06-02	Exercise	389.79K	—	2025-06-02	2026-07-13
Hayward Marshall A. Chief Scientific Officer · Restricted Stock Award · 2025-06-02	Exercise	399.4K	—	2025-06-02	2026-07-13
Hemmerly Nicholas H. Director · Common Stock · 2025-06-02	Exercise	95.55K	—	2025-06-02	2026-07-13
Hemmerly Nicholas H. Director · Restricted Stock Units · 2025-06-02	Exercise	95.55K	—	2025-06-02	2026-07-13
Weis Holger Director · Common Stock · 2025-06-02	Exercise	85.8K	—	2025-06-02	2026-07-13
Weis Holger Director · Restricted Stock Units · 2025-06-02	Exercise	85.8K	—	2025-06-02	2026-07-13
Rosen Alexander Gustaf Erik Chief Administrative Officer · Common Stock · 2025-06-02	Exercise	164.55K	—	2025-06-02	2026-07-13

SEC filings

EDGAR filings in JUNS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.